Evidence map›Paper›PMID 29651030›Full record

ArticleScientific reports2018

Publisher Correction: Impaired oxidative stress response characterizes HUWE1-promoted X-linked intellectual disability.

Matthias Bosshard, Rossana Aprigliano, Cristina Gattiker, Vuk Palibrk, Enni Markkanen, Paul Hoff Backe, Stefania Pellegrino, F Lucy Raymond, Guy Froyen, Matthias Altmeyer and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Matthias BosshardDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland.
Rossana ApriglianoDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland.
Cristina GattikerDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland.
Vuk PalibrkDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, 7491, Norway.
Enni MarkkanenDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland.
Paul Hoff BackeInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, 0318, Norway.
Stefania PellegrinoDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland.
F Lucy RaymondDepartment of Medical Genetics, Cambridge Institute for Medical Research, Cambridge, CB2 0XY, United Kingdom.
Guy FroyenHuman Genome Laboratory, Department of Human Genetics, Leuven, 3000KU, Belgium.
Matthias AltmeyerDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland.
Magnar BjøråsDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, 7491, Norway.
Grigory L DianovCRUK/MRC Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.
Barbara van LoonDepartment of Molecular Mechanisms of Disease, University of Zurich, Zürich, 8057, Switzerland. barbara.v.loon@ntnu.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Identifiers

PMID29651030
PMCPMC5897351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.